CURCUMIN-QINGDAI (CURQD) IN COMBINATION WITH VEDOLIZUMAB VERSUS VEDOLIZUMAB ALONE AS INDUCTION AND MAINTENANCE THERAPY IN ULCERATIVE COLITIS
$811,213FY2025Defense Health AgencyDOD
Icahn School Of Medicine At Mount Sinai, New York NY
Icahn School Of Medicine At Mount Sinai, New York NY